Monoclonal proliferation of double‐negative (CD4CD8) T‐cells bearing T‐Cell receptor‐αβ followed by subsequent development of Hodgkin's disease

Mitsuru Matsumoto, Kiyonori Takada, Takaaki Hato, Takahiko Horiuchi, Masaki Yasukawa, Shinichi Murao, Shigeru Fujita

Research output: Contribution to journalArticlepeer-review

Abstract

Expression of CD4 or CD8 on the cell surface is an important guide for discriminating the immunologic functions of T‐cells. However, a minor T‐cell subset lacking both CD4 and CD8 molecules but bearing the usual form of T‐cell receptor (TCR)‐αβ (CD4CD8TCR‐αβ+ T‐cells) has recently been found not only in mice but also in humans, and the clinical relevance of this newly defined subpopulation to human diseases is now of considerable interest. The authors present a patient in whom CD4CD8TCR‐αβ+ T‐cells showed monoclonal proliferation in the peripheral blood for more than 3 years, then disappeared spontaneously, followed by subsequent development of Hodgkin's disease. The pathologic roles of double‐negative T‐cell proliferation in this case are discussed from the viewpoint of premalignancy in lymphoproliferative diseases. Cancer 1994; 73:2818–23.

Original languageEnglish
Pages (from-to)2818-2823
Number of pages6
JournalCancer
Volume73
Issue number11
DOIs
Publication statusPublished - Jun 1 1994
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Monoclonal proliferation of double‐negative (CD4<sup>−</sup>CD8<sup>−</sup>) T‐cells bearing T‐Cell receptor‐αβ followed by subsequent development of Hodgkin's disease'. Together they form a unique fingerprint.

Cite this